This section is intended for patients prescribed Alunbrig. If you are a member of the public click here. If you are a UK healthcare professional click here.

Your guide to taking once-daily Alunbrig  (brigatinib)

This website has been provided for patients prescribed Alunbrig for anaplastic lymphoma kinase positive (ALK+) advanced non-small lung cancer (aNSCLC) after previous crizotinib treatment. It explains how Alunbrig works, how to take Alunbrig and the possible side effects you may experience.

This website does not replace your healthcare professional’s advice. Always ask your doctor, nurse or pharmacist any questions you might have about your treatment or disease.

Please read the Patient Information Leaflet for full information and carry your Patient Alert Card with you and show your card to any doctor or healthcare professional you see.

Patient Alert Card thumbnail

Patient Alert Card

Carry this card with you at all times and take it with you to any medical appointments you may have. You should present it to any doctors or nurses treating you, even if they are not your usual treating oncologist or lung nurse.

Patient booklet thumbnail

My Patient Booklet

This guide contains information for people taking Alunbrig for the treatment of ALK-positive advanced non-small cell lung cancer (aNSCLC) after previous crizotinib treatment. It also contains the patient alert card.

Download booklet